MARIE MCCORMICK: Open Payments
NPI 1376517631 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $201 |
| Amgen Inc. | 1 | $127 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $6 |
Products named: REPATHA, OPSUMIT, ELIQUIS, DEFINITY, LEQVIO, SHINGRIX, LifeVest.
Industry payments across AZ — which companies pay providers there.
